I have a profound interest in translational cancer research, with a particular focus on hematological malignancies. My expertise spans cancer cell characterization across multiple platforms: from basic molecular biology and tumor microenvironment description to advanced methodologies such as large-scale proteomics and imaging flow cytometry-based cell classification. Additionally, I actively investigate novel gene-editing therapeutics.
By integrating these diverse approaches, my work aims to develop clinically applicable diagnostics and therapies for cancer patients facing currently unmet medical needs. My overarching goal is to bridge the gap between bench and bedside, accelerating the translation of scientific discoveries into impactful clinical interventions.
For more information, please visit my research group's web page:
https://clin.au.dk/hemelab